Gene-blocking therapy reverses Alzheimer’s-like symptoms … New bill would increase temp worker protections … Projected $10 trillion federal debt growth over next decade may affect plans...
Report: Alzheimer’s is costliest disease in United States
By
Lois A. Bowers
Apr 04, 2016
A new report from the Alzheimer’s Association provides updated information on the current and predicted prevalence and cost of Alzheimer’s disease.
What you need to know about the Democratic platform
By
Lois A. Bowers
Jul 26, 2016
The Democratic National Convention ratified the party platform late Monday in Philadelphia. We’ve highlighted topics in the 55-page document that will be of particular interest to those working in...
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
More news for Tuesday, Feb. 7
Feb 06, 2017
Search for Alzheimer’s drugs is more urgent than ever … How would Republican plans for Medicaid block grants actually work? … Long-term care advocates call on Canadian government to invest...
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
NCBAC Alzheimer Caregiver Guide approved for Florida direct-care workers
Feb 22, 2016
The state of Florida now recognizes the National Certification Board for Alzheimer Care’s Alzheimer Caregiver Guide to meet the four-hour training requirement for direct care workers in assisted...
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
CCAs can lower person-centered dementia care costs
By
Lois A. Bowers
Apr 10, 2016
Care coordinator assistants can be a low-cost way to facilitate person-centered care for those with dementia and their caregivers, according to a new study.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.